Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: A cohort study

Lancet

Volumn 361, Issue 9353, 2003, Pages 195-200

  Younis, Naveed ^a,b   Broadbent, Deborah M ^a   Vora, Jiten P ^a   Harding, Simon P ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; EYE PHOTOGRAPHY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETINA MACULOPATHY; UNITED KINGDOM;

EID: 0037452226     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12267-2     Document Type: Article

References (34)

1. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 81:1976;383-396.
2. Photocoagulation for diabetic maculopathy: a randomized controlled clinical trial using the xenon arc. Diabetes. 32:1983;1010-1016.
3. Klein R., Klein B.E.K., Moss S.E. Visual impairment in diabetes. Ophthalmology. 91:1984;1-9.
4. A protocol for screening for diabetic retinopathy in Europe. Diabet Med. 8:1991;263-267.
5. Garvican L., Clowes J., Gillow T. Preservation of sight in diabetes: developing a national risk reduction programme. Diabet Med. 17:2000;627-634.
6. National Eye Health Education Program. Congressional record, National Departments of Labor, Health and Human Services, Education, and related agencies. Appropriation Bill, 1988: 100-89.
7. Harding S.P., Broadbent D.M., Neoh C., White M.C., Vora J. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study. BMJ. 311:1995;1131-1135.
8. Klein R., Klein B.E., Neider M.W., Hubbard L.D., Meuer S.M., Brothers R.J. Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology. 92:1985;485-491.
9. Klein R., Klein B.E., Moss S.E., Davis M.D., DeMets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol. 107:1989;244-249.
10. Kristinsson J.K., Stefánsson E., Jónasson F., Gíslason I., Björnsson S. Screening for eye disease in type 2 diabetes mellitus. Acta Ophthalmol Scand. 72:1994;341-346.
11. Henricsson M., Groop L., Heijl A. Progression of retinopathy is related to glycaemic control even in patients with mild diabetes mellitus. Acta Ophthalmol Scand. 74:1996;528-532.
12. Stratton I.M., Kohner E.M., Aldington S.J., et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 44:2001;156-163.
13. Kohner E.M., Stratton I.M., Aldington S.J., Holman R.R., Matthews D.R. Relationship between the severity of retinopathy and progression to photocoagulation in patients with type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med. 18:2001;178-184.
14. Diabetic retinopathy. Diabetes Care. 21:1998;157-159.
15. The Royal College of Ophthalmologists. Guidelines for diabetic retinopathy. London: The Royal College of Ophthalmologists, 1997.
16. Bachmann M.O., Nelson S.J. Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model. J Epidemiol Community Health. 52:1998;45-52.
17. Broadbent D.M., Harding S.P., James M., Vora J.P. Does stereoscopic macular photography improve the detection of macular oedema: a further sensitivity analysis. Diabet Med. 17:(suppl):2000;P69.
18. Broadbent D.M., Scott J.A., Vora J.P., Harding S.P. Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye. 13:1999;160-165.
19. James M., Turner D.A., Broadbent D.M., Vora J., Harding S.P. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ. 320:2000;1627-1631.
20. Grading diabetic retinopathy from stereoscopic colour fundus photographs: an extension of the modified Airlie House Classification. ETRS Report number 10. Ophthalmology. 98:1991;786-806.
21. Klein R., Klein B.E.K., Moss S.E., Davis M.D., DeMets D.L. The Wisconsin Epidemilogic study of Diabetic Retinopathy IV: Diabetic Macular Edema. Ophthalmology. 91:1984;1464-1474.
22. Lee E.T., Lee V.S., Kingsley R.M., et al. Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors. Diabetes Care. 15:1992;1620-1627.
23. Teuscher A., Schnell H., Wilson P.W.F. Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care. 11:1988;246-251.
24. Dwyer M.S., Melton L.J.d, Ballard D.J., Palumbo P.J., Trautmann J.C., Chu C.P. Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota. Diabetes Care. 8:1985;316-322.
25. Henricsson M., Sellman A., Tyrberg M., Groop L. Progression to proliferative retinopathy and macular oedema requiring treatment: assessment of the alternative classification of the Wisconsin Study. Acta Ophthalmol Scand. 77:1999;218-223.
26. Nielsen N.V. Diabetic retinopathy II. The course of retinopathy in diabetics treated with oral hypoglycaemic agents and diet regime alone: a one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol (Copenh). 62:1984;266-273.
27. Henricsson M., Nilsson A., Groop L., Heijl A., Janzon L. Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control. Acta Ophthalmol Scand. 74:1996;523-527.
28. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352:1998;837-853.
29. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 317:1998;703-713.
30. Klein R., Klein B.E.K., Moss S.E., Davis M.D., De Mets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy III: Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 102:1984;527-532.
31. Klein R., Klein B.E., Moss S.E., Cruickshanks K.J. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 112:1994;1217-1228.
32. Vijan S., Hofer T.P., Hayward R.A. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 283:2000;889-896.
33. American Academy of Ophthalmology. Comprehensive adult eye evaluation, preferred practice pattern. San Francisco: American Academy of Ophthalmology, 1992.
34. Taylor R., Broadbent D.M., Greenwood R., Hepburn D., Owens D.R., Simpson H. Mobile retinal screening in Britain. Diabet Med. 15:1998;344-347.